PatentDocs
- Yesterday, Dr. Tafas filed a reply to the GSK/USPTO joint motion to dismiss GSK v. Kappos, seeking resolution of remaining issues.9:06 AM Oct 20th from web
- The USPTO is set to announce the rescission of the "Controversial Patent Regulations Package Proposed by Previous Administration."1:14 PM Oct 8th from web
- The U.S. Patent and Trademark Office introduced a new web interface today.9:23 AM Oct 8th from web
- The USPTO has announced that Chicago-based Foley & Lardner attorney Sharon Barner has been appointed USPTO Deputy Director.1:11 PM Oct 2nd from web
- Oral argument in Bilski v. Kappos has been scheduled for Monday, November 9, 2009.12:33 PM Aug 24th from web
- Oral argument in Wyeth v. Kappos (appeal regarding construction of ยง 154(b)(2)(A)) has been scheduled for Wednesday, October 7, 2009.8:27 AM Aug 24th from web
- The Federal Circuit has granted Ariad's petition for rehearing en banc in Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co.2:05 PM Aug 21st from web
- The AIPLA is reporting that the U.S. Senate has confirmed David Kappos as Director of the U.S. Patent and Trademark Office.11:50 AM Aug 7th from web
- Hal Wegner is reporting that the DOJ is seeking to defer the Tafas v. Doll en banc hearing until the new Director can review the case.8:37 AM Jul 27th from web
- The CAFC has granted GSK's petition for rehearing en banc in Tafas v. Dudas.2:08 PM Jul 6th from web
- For a report on the White House follow-on biologics letter, please visit: 8:36 AM Jun 26th from web
- Reuters reports that the White House has sent a letter to Rep. Waxman recommending a 7-year data exclusivity period for follow-on biologics.7:23 AM Jun 26th from web
- Senator Patrick Leahy has released a statement announcing that President Obama intends to nominate David Kappos as USPTO Director.2:08 PM Jun 18th from web
- The USPTO has announced the release of a beta version of its new website: 2:12 PM Jun 11th from web
|
- Name Donald Zuhn
- Location Chicago, IL
- Web http://www.patent...
- Bio I am a patent attorney who represents companies, universities, and inventors in the life sciences industry.
|